Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

ClinicalTrials.gov ID: NCT01437657

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01437657. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 1:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Study of the Safety and Efficacy of RO4917523 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder With Inadequate Response to Ongoing Antidepressant Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, double-blind, placebo-controlled, parallel group study will evaluate the safety and efficacy of RO4917523 as adjunctive therapy in patients with major depressive disorder and an inadequate response to ongoing antidepressant therapy. Anticipated time on study treatment is 6 weeks with a 3-week follow-up.

Study identification

NCT ID
NCT01437657
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
319 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2011 (Type not available)
Primary completion
Sep 2013 (Actual)
Completion
Sep 2013 (Actual)
Last update posted
Nov 2, 2016

2011 – 2013

United States locations

U.S. sites
28
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72223 —
Not listed Costa Mesa California 92626 —
Not listed Garden Grove California 92845 —
Not listed Oceanside California 92056 —
Not listed Orange California 92868 —
Not listed Riverside California 92506 —
Not listed San Diego California 92102 —
Not listed San Diego California 92103 —
Not listed San Diego California 92121 —
Not listed Santa Ana California 92705 —
Not listed Wildomar California 92595 —
Not listed Atlanta Georgia 30328 —
Not listed Libertyville Illinois 60048 —
Not listed Naperville Illinois 60563 —
Not listed Oak Brook Illinois 60523 —
Not listed Shreveport Louisiana 71115 —
Not listed Baltimore Maryland 21285 —
Not listed Las Vegas Nevada 89102 —
Not listed Marlton New Jersey 08053 —
Not listed Brooklyn New York 11201 —
Not listed Cedarhurst New York 11516 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Norristown Pennsylvania 19403 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Philadelphia Pennsylvania 19139 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Memphis Tennessee 38119 —
Not listed Kirkland Washington 98033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01437657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2016 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.